These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6329822)

  • 1. Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes.
    Robberecht P; Waelbroeck M; de Neef P; Camus JC; Vandermeers A; Vandermeers-Piret MC; Christophe J
    FEBS Lett; 1984 Jun; 172(1):55-8. PubMed ID: 6329822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
    Robberecht P; Waelbroeck M; De Neef P; Tastenoy M; Gourlet P; Cogniaux J; Christophe J
    FEBS Lett; 1988 Feb; 228(2):351-5. PubMed ID: 2830146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of synthetic N- and C-terminal fragments of helodermin with rat liver VIP receptors.
    Robberecht P; Yanaihara N; Yanaihara C; De Neef P; Camus JC; Vandermeers A; Vandermeers-Piret MC; Christophe J
    Peptides; 1986; 7 Suppl 1():79-82. PubMed ID: 3018706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that helodermin, a newly extracted peptide from Gila monster venom, is a member of the secretin/VIP/PHI family of peptides with an original pattern of biological properties.
    Robberecht P; Waelbroeck M; Dehaye JP; Winand J; Vandermeers A; Vandermeers-Piret MC; Christophe J
    FEBS Lett; 1984 Jan; 166(2):277-82. PubMed ID: 6319194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin.
    Laburthe M; Amiranoff B; Boige N; Rouyer-Fessard C; Tatemoto K; Moroder L
    FEBS Lett; 1983 Aug; 159(1-2):89-92. PubMed ID: 6307754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of Gila monster venom with secretin receptors in rat pancreatic membranes.
    Gillet L; Robberecht P; Waelbroeck M; Camus JC; De Neef P; König W; Christophe J
    Peptides; 1984; 5(2):407-9. PubMed ID: 6089139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
    Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
    Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of VIP-secretin receptors in rat and human lung.
    Christophe J; Chatelain P; Taton G; Delhaye M; Waelbroeck M; Robberecht P
    Peptides; 1981; 2 Suppl 2():253-8. PubMed ID: 6123988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of vasoactive intestinal peptide receptors in human liver.
    Rodríguez-Henche N; Rodríguez-Pena MS; Guijarro LG; Prieto JC
    Biochim Biophys Acta; 1994 Mar; 1221(2):193-8. PubMed ID: 8148398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
    Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers A; Vandermeers-Piret MC; Robberecht P; Christophe J
    Biochim Biophys Acta; 1991 Jul; 1066(2):245-51. PubMed ID: 1649637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes.
    Robberecht P; Waelbroeck M; De Neef P; Camus JC; Gourlet P; Christophe J
    Life Sci; 1988; 42(5):505-10. PubMed ID: 2828794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes.
    Robberecht P; Chatelain P; De Neef P; Camus JC; Waelbroeck M; Christophe J
    Biochim Biophys Acta; 1981 Nov; 678(1):76-82. PubMed ID: 6118184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J; Waelbroeck M; Chatelain P; Robberecht P
    Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP- and secretin-like properties (helodermin) from Gila monster venom.
    Vandermeers A; Vandermeers-Piret MC; Robberecht P; Waelbroeck M; Dehaye JP; Winand J; Christophe J
    FEBS Lett; 1984 Jan; 166(2):273-6. PubMed ID: 6692928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PACAP and VIP receptors in rat liver membranes.
    Robberecht P; Gourlet P; Cauvin A; Buscail L; De Neef P; Arimura A; Christophe J
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G97-102. PubMed ID: 1846275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1986 Aug; 159(1):45-9. PubMed ID: 3017717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.
    Robberecht P; Tatemoto K; Chatelain P; Waelbroeck M; Delhaye M; Taton G; De Neef P; Camus JC; Heuse D; Christophe J
    Regul Pept; 1982 Oct; 4(5):241-50. PubMed ID: 6294750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.